S. 64 · 116th Congress

Preserve Access to Affordable Generics and Biosimilars Act

Stage
In committee
Introduced
2019-01-09
Latest action
2019-01-09 · Introduced in Senate

Subjects

Administrative law and regulatory procedures
Health
Civil actions and liability
Licensing and registrations
Intellectual property
Prescription drugs
Marketing and advertising
Competition and antitrust
Manufacturing
Judicial review and appeals
Contracts and agency
Federal Trade Commission (FTC)